Jones Trading Initiates Coverage on Palvella Therapeutics (NASDAQ:PVLA)
Stock analysts at Jones Trading started coverage on shares of Palvella Therapeutics (NASDAQ:PVLA – Get Free Report) in a report released on Tuesday,Benzinga reports. The brokerage set a “buy” rating and a $45.00 price target on the stock. Jones Trading’s price target indicates a potential upside of 61.12% from the company’s previous close. Several other […]
